120 related articles for article (PubMed ID: 8584886)
1. [Progress in the study of cyclic nucleotide phosphodiesterases].
Zhou HL; Bian RL
Sheng Li Ke Xue Jin Zhan; 1995 Jul; 26(3):213-7. PubMed ID: 8584886
[TBL] [Abstract][Full Text] [Related]
2. [Cyclic nucleotide phosphodiesterases: diversity, classification, structure and function].
Rascón A
Acta Cient Venez; 1997; 48(3):145-53. PubMed ID: 9640674
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanisms of particulate cyclic nucleotide phosphodiesterases.
Thompson WJ; Lavis VR; Whalin ME; Strada SJ
Adv Second Messenger Phosphoprotein Res; 1992; 25():165-84. PubMed ID: 1313258
[No Abstract] [Full Text] [Related]
4. Modulation of cyclic nucleotides and cyclic nucleotide phosphodiesterases in pancreatic islet beta-cells and intestinal L-cells as targets for treating diabetes mellitus.
Furman B; Pyne N
Curr Opin Investig Drugs; 2006 Oct; 7(10):898-905. PubMed ID: 17086934
[TBL] [Abstract][Full Text] [Related]
5. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
Zhou L; Thompson WJ; Potter DE
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.
Nicholson CD; Challiss RA; Shahid M
Trends Pharmacol Sci; 1991 Jan; 12(1):19-27. PubMed ID: 1848733
[TBL] [Abstract][Full Text] [Related]
7. Assessment of phosphodiesterase isozyme contribution in cell and tissue extracts.
Keravis T; Thaseldar-Roumié R; Lugnier C
Methods Mol Biol; 2005; 307():63-74. PubMed ID: 15988055
[TBL] [Abstract][Full Text] [Related]
8. Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma.
Raeburn D; Souness JE; Tomkinson A; Karlsson JA
Prog Drug Res; 1993; 40():9-32. PubMed ID: 8395068
[No Abstract] [Full Text] [Related]
9. Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function.
Thompson WJ
Pharmacol Ther; 1991; 51(1):13-33. PubMed ID: 1663250
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside 3',5'-cyclic monophosphate metabolites of purine analogs. Possible role as physiological mediators.
Zimmerman TP
Biochem Pharmacol; 1979 Sep; 28(17):2533-9. PubMed ID: 229855
[No Abstract] [Full Text] [Related]
11. Cyclic nucleotide metabolism in the vertebrate retina.
Lolley RN
Curr Top Eye Res; 1980; 2():67-118. PubMed ID: 6284444
[No Abstract] [Full Text] [Related]
12. Cyclic nucleotide phosphodiesterases in the circulatory system. Biochemical, pharmacological, and functional characteristics.
Weishaar RE; Kobylarz-Singer D; Keiser JA; Wright CD; Cornicelli J; Panek R
Adv Second Messenger Phosphoprotein Res; 1992; 25():249-69. PubMed ID: 1313261
[No Abstract] [Full Text] [Related]
13. Three-dimensional structure of a cyclic-nucleotide phosphodiesterase from human brain.
Sakamoto Y; Tanaka N; Ichimiya T; Kurihara T; Nakamura KT
Nucleic Acids Symp Ser (Oxf); 2004; (48):157-8. PubMed ID: 17150526
[TBL] [Abstract][Full Text] [Related]
14. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.
Beavo JA; Reifsnyder DH
Trends Pharmacol Sci; 1990 Apr; 11(4):150-5. PubMed ID: 2159198
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
Netherton SJ; Maurice DH
Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
[TBL] [Abstract][Full Text] [Related]
16. Characterization by DEAE-cellulose chromatography of a single molecular form of cyclic nucleotide phosphodiesterase in the myometrium of nonpregnant women.
Leroy MJ; Blot P; Ferré F
Gynecol Obstet Invest; 1987; 24(3):190-9. PubMed ID: 2826314
[TBL] [Abstract][Full Text] [Related]
17. Multiple isozymes of cyclic nucleotide phosphodiesterase.
Beavo JA
Adv Second Messenger Phosphoprotein Res; 1988; 22():1-38. PubMed ID: 2852020
[No Abstract] [Full Text] [Related]
18. The N-terminal domain of 2',3'-cyclic nucleotide 3'-phosphodiesterase harbors a GTP/ATP binding site.
Stingo S; Masullo M; Polverini E; Laezza C; Ruggiero I; Arcone R; Ruozi E; Dal Piaz F; Malfitano AM; D'Ursi AM; Bifulco M
Chem Biol Drug Des; 2007 Dec; 70(6):502-10. PubMed ID: 17986204
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
20. Molecular properties of cyclic nucleotide phosphodiesterase isozymes.
Strada SJ; Kithas PA; Whalin ME; Thompson WJ
Adv Exp Med Biol; 1989; 255():409-23. PubMed ID: 2559603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
